The Disease Forecasting Company.
Independent disease forecasting and health intelligence. Cited over 70,000 times
Analysis & Insights
Is the world ready for a bird flu pandemic? Airfinity assesses global vaccine stockpiles and preparedness
Read More →
More from Airfinity
A New Era in Immunisation: Forecasting the Future of Combination Respiratory Vaccines
Airfinity Wins FT Tech Champions 2023
Airfinity Wins Bloomberg Top 25 UK Startups to Watch
What other conditions could weight-loss drugs treat?
Global surge in infectious diseases as over 40 countries report outbreaks 10-fold over pre-pandemic levels
The West should be on a war footing for the next pandemic
View All →
In the News
Trump administration cancels multi-million dollar bird flu vaccine contract with Moderna
The Telegraph | May 29, 2025
EU shores up pandemic defences with 478m flu vaccine deal
The Telegraph | May 7, 2025
The future of weight loss drugs: gummies, tablets and melt-in-the-mouth strips
The i Paper | Mar 28, 2025
Value of investment on NCDs: Impact on health outcomes in low- and middle-income countries
IFPMA | Mar 11, 2025
View All →
A pioneer in predictive health intelligence
Understand
What's happening in a given disease area?
Airfinity is the most comprehensive, single source of intelligence for new developments in your chosen area.
Predict
Identify the true need for a vaccine or a treatment.
Our suite of dynamic predictive indicators help you navigate highly dynamic and uncertain market developments and see the real opportunities.
Act
Maximise impact to save lives
Our analytics and probabilistic tools inform key decisions on resource allocation, investment and procurement decisions to maximise impact of a given drug or vaccine and ultimately improve as many lives as possible.
Analyse, simulate, and predict the changing health landscape
Airfinity develops and deploys dynamic disease forecasting models to support horizon scanning, medical countermeasure impact modelling, clinical trial site optimisation, scenario-based demand intelligence, portfolio optimisation and more.
What our users say?
“Airfinity has again and again shown they can provide very accurate and actionable predictions for disease trajectories. That’s why their analytics became an essential tool for me and the White House when leading outbreak responses such as COVID-19, mpox, Marburg Virus Disease and Avian Flu.”
Nikki Romanik, Former Special Assistant to the President, Deputy Director and Chief of Staff,
Office of Pandemic Preparedness and Response Policy, White House
In a dynamic environment, Airfinity enabled us to remain on track with daily developments to enable more accurate decision-making. Airfinity combines nimbleness of real time data and their group of scientists that can analyse, model and provide strategic analysis for critical decision making.”
Iskra Reic, Executive Vice-President
Astrazeneca
“The Airfinity report is a guide for world leaders to fix a more ambitious action plan.”
Gordon Brown, WHO Ambassador for Global Health Financing & former UK Prime Minister
“Airfinity has been instrumental in our country's COVID response.”
Head of UK Government
Vaccine Task Force
“Probably the most expansive, accurate and helpful of the multiple data sets on an international scale”
Sir John Bell ,
University of Oxford